Orphazyme A/S ADR (ORPH) Social Stream



Orphazyme A/S ADR (ORPH): $0.87

-0.02 (-2.25%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add ORPH to Watchlist
Sign Up

Industry: Biotech


Ranked

of 414

in industry

Orphazyme A (ORPH) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering ORPH.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-02-23 3 $1 $1 $1 $0.87 14.94%
2022-03-11 2 $1 $1 $1 $0.87 14.94%

ORPH reports an average of -32.76% for its upside potential over the past 164 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-28 3 1 1 1 4.210 -76.25%
2022-02-23 2 1 1 1 2.020 -50.5%
2022-02-23 3 1 1 1 2.020 -50.5%
2022-03-11 2 1 1 1 0.684 46.2%

ORPH Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
4.5 0 0 0 1 1 2

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ORPH as an investment opportunity.

  • In terms of how Orphazyme A fares relative to all US stocks, note that its variance in analysts' estimates is lower than just about 100% of that group.
  • In terms of how Orphazyme A fares relative to all US stocks, note that its average analyst price target is greater than 0.08% of that group.
  • In the context of Pharmaceutical Products stocks, Orphazyme A's upside potential (average analyst target price relative to current price) is higher than 14.32% of them.
  • In terms of how Orphazyme A fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 17.25% of that group.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Orphazyme A are ORMP, ORIC, and OPTN.

Is ORPH a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.492 seconds.